Prediction of COVID‐19 severity using machine learning

COVIRNA consortium, Kanita Karaduzovic‐Hadziabdic, Muhamed Adilovic, Lu Zhang, Andrew I Lumley, Pranay Shah, Muhammad Shoaib, Venkata Satagopam, Prashant Kumar Srivastava, Costanza Emanueli, Simona Greco, Alisia Madè, Teresa Padro, Pedro Domingo, Mitja Lustrek, Markus Scholz, Maciej Rosolowski, Marko Jordan, Bettina Benczik, Bence ÁggPéter Ferdinandy, Andrew H Baker, Guy Fagherazzi, Markus Ollert, Joanna Michel, Gabriel Sanchez, Hüseyin Firat, Timo Brandenburger, Fabio Martelli, Lina Badimon, Yvan Devaux

Research output: Contribution to journalLetterpeer-review

Abstract

YD holds patents and licensing agreements related to the use of RNAs for diagnostic and therapeutic purposes (WO2018229046, licensed to Firalis SA, protecting the use of lncRNAs in the FIMICS panel used for RNAseq in the present paper; other patents and licenses are not related to the present work). YD is Scientific Advisory Board member of Firalis SA. PF is the founder and CEO of Pharmahungary Group, a group of R&D companies. LB declares to have acted as a SAB member of Sanofi, Ionnis, MSD and NovoNordisk; to have received speaker fees from Sanofi, Bayer and AB‐Biotics SA and to have founded the spin‐off Ivastatin Therapeutics S.L. (all unrelated to this work). TP declares to have received speaker fees from AB‐Biotics SA and to be a co‐founder of the Spin‐off Ivastatin Therapeutics SL (all unrelated to this work). MS received funding from Pfizer Inc. and from Owkin for projects not related to this research. HF is the founder and owner of Firalis SA, a company commercialising the FIMICS panel. He holds patents and licenses for the use of RNAs as biomarkers and therapeutic targets. All other authors declare no competing interests.
Original languageEnglish
JournalClinical and Translational Medicine
Volume14
Issue number10
Early online date6 Oct 2024
DOIs
Publication statusPublished - 14 Oct 2024

Fingerprint

Dive into the research topics of 'Prediction of COVID‐19 severity using machine learning'. Together they form a unique fingerprint.

Cite this